Sound wave therapy may spark immune attack on liver tumors
NCT ID NCT07361107
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This early study tests whether a non-invasive sound wave procedure called histotripsy can stir up the immune system in people with colorectal cancer that has spread to the liver. Researchers will take blood samples before and after treatment to see if T-cells become more active. Only 12 people will take part, and the goal is to understand the immune response, not yet to treat the cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Histotripsy (a non-invasive procedure using sound waves to destroy tumors)
- What this could lead to
- If it works, this could point toward combining histotripsy with immunotherapy to better treat colorectal cancer that has spread to the liver.
- What could go wrong
- This is a very early, small pilot study with only 12 people. It is designed to measure immune changes, not to prove the treatment works. The results may not lead to any new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL (COLON OR RECTAL) CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zuckerberg Cancer Center
RECRUITINGNew Hyde Park, New York, 11040, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New model could spot dangerous surgical leaks before they happen
- Can a simple blood test predict leukemia risk after cancer therapy?
- Immunotherapy may let some GI cancer patients skip the knife
- New hope for stomach cancer: experimental drug BHB810 enters human trials
- New online program aims to ease cancer treatment side effects
- New study aims to predict who benefits from abdominal cancer surgery